Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B ROTHMAN

Showing results (331-340 of 606) with videos related to

Pageof 61
Sort By:
Progress in Clinical and Biological Research|January 1, 1990
The affinity ligand "UPHIT" acylates kappa opioid binding sites in vivoL Band, B R de Costa, V Bykov, et al.
Neurochemical Research|March 1, 1992
MPTP lesions of the nigrostriatal dopaminergic projection decrease [3H]1-[1-(2-thienyl)cyclohexyl]piperidine binding to PCP site 2: further evidence that PCP site 2 is associated with the biogenic amine reuptake complexH C Akunne, J N Johannessen, B R de Costa, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivoE J Bilsky, R N Bernstein, V J Hruby, et al.
Methods in Enzymology|November 2, 2010
In vitro and in vivo assessment of mu opioid receptor constitutive activityEdward J Bilsky, Denise Giuvelis, Melissa D Osborn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 15, 2009
Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the ratMichael H Baumann, Dorota Zolkowska, Insook Kim, et al.
Neuroreport|October 27, 1994
Pharmacological characterization of the cloned kappa opioid receptor as a kappa 1b subtypeJ Lai, S W Ma, R H Zhu, et al.
Annals of the New York Academy of Sciences|November 16, 2004
Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expressionRichard B Rothman, Subramaniam Jayanthi, Jean L Cadet, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Libraries of opiate and anti-opiate peptidomimetics containing 2,3-methanoleucineK Burgess, W Li, D S Linthicum, et al.
Journal of Hepatology|May 1, 1992
Central mu-opioid receptors are down-regulated in a rat model of cholestasisN V Bergasa, R B Rothman, J Vergalla, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 29, 2005
Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogsS Wee, K G Anderson, M H Baumann, et al.
Pageof 61

Showing results (331-340 of 606) with videos related to

Sort By:
Pageof 61
Progress in Clinical and Biological Research|January 1, 1990
The affinity ligand "UPHIT" acylates kappa opioid binding sites in vivoL Band, B R de Costa, V Bykov, et al.
Neurochemical Research|March 1, 1992
MPTP lesions of the nigrostriatal dopaminergic projection decrease [3H]1-[1-(2-thienyl)cyclohexyl]piperidine binding to PCP site 2: further evidence that PCP site 2 is associated with the biogenic amine reuptake complexH C Akunne, J N Johannessen, B R de Costa, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivoE J Bilsky, R N Bernstein, V J Hruby, et al.
Methods in Enzymology|November 2, 2010
In vitro and in vivo assessment of mu opioid receptor constitutive activityEdward J Bilsky, Denise Giuvelis, Melissa D Osborn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 15, 2009
Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the ratMichael H Baumann, Dorota Zolkowska, Insook Kim, et al.
Neuroreport|October 27, 1994
Pharmacological characterization of the cloned kappa opioid receptor as a kappa 1b subtypeJ Lai, S W Ma, R H Zhu, et al.
Annals of the New York Academy of Sciences|November 16, 2004
Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expressionRichard B Rothman, Subramaniam Jayanthi, Jean L Cadet, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Libraries of opiate and anti-opiate peptidomimetics containing 2,3-methanoleucineK Burgess, W Li, D S Linthicum, et al.
Journal of Hepatology|May 1, 1992
Central mu-opioid receptors are down-regulated in a rat model of cholestasisN V Bergasa, R B Rothman, J Vergalla, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 29, 2005
Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogsS Wee, K G Anderson, M H Baumann, et al.
Pageof 61